Cambridge Investment Research Advisors, Inc. Zentek Ltd. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Zentek Ltd. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,500 shares of ZTEK stock, worth $16,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,500
Previous 21,500
4.65%
Holding current value
$16,400
Previous $23,000
30.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ZTEK
# of Institutions
26Shares Held
1.81MCall Options Held
0Put Options Held
0-
Scotia Capital Inc.881KShares$704,9600.0% of portfolio
-
Royal Bank Of Canada Toronto, A6271KShares$217,1450.0% of portfolio
-
Federation Des Caisses Desjardins Du Quebec Levis, A8152KShares$121,3200.0% of portfolio
-
Cibc World Market Inc. Toronto, A6141KShares$113,0030.0% of portfolio
-
Bank Of Montreal Toronto, A656.5KShares$45,1700.0% of portfolio
About Zentek Ltd.
- Ticker ZTEK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 99,363,104
- Market Cap $79.5M
- Description
- Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detec...